Cumberland Pharmaceuticals, Inc. (CPIX)
-NasdaqGS 4.75 
0.05(1.06%) 4:00PM EDT
| Prev Close: | 4.70 |
|---|
| Open: | 4.72 |
|---|
| Bid: | 1.00 x 1000 |
|---|
| Ask: | 5.05 x 1000 |
|---|
| 1y Target Est: | 5.50 |
|---|
| Beta: | 1.34 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 4.68 - 4.80 |
|---|
| 52wk Range: | 4.03 - 6.85 |
|---|
| Volume: | 13,276 |
|---|
| Avg Vol (3m): | 63,848 |
|---|
| Market Cap: | 87.61M |
|---|
| P/E (ttm): | 14.57 |
|---|
| EPS (ttm): | 0.33 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Cumberland Pharma On The Right Track... But Moving Slowlyat Seeking Alpha(Wed, May 22)
- Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New YorkPR Newswire(Wed, May 15)
- CUMBERLAND PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Tue, May 14)
- CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, May 7)
- 1 Winner and 4 Losers from This Week’s Earnings Stormat Wall St. Cheat Sheet(Sat, May 4)
- Cumberland Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 3)
- CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Fri, May 3)
- Cumberland Pharmaceuticals Earnings: Here’s Why Investors are Buying Shares Nowat Wall St. Cheat Sheet(Thu, May 2)
- Cumberland Pharmaceuticals Reports First Quarter Financial ResultsPR Newswire(Thu, May 2)
- Cumberland Pharmaceuticals To Announce First Quarter 2013 Financial Results On May 2, 2013PR Newswire(Thu, Apr 25)
- CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Fri, Apr 19)
- CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other EventsEDGAR Online(Mon, Apr 8)
- CUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual ReportEDGAR Online(Tue, Mar 12)
- CUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial ConditionEDGAR Online(Mon, Mar 4)
- New Star Analyst Rankings for Cumberland Pharmaceuticals Inc.StarMine(Sat, Mar 2)
Key Statistics
| Forward P/E (1 yr): | 95.00 |
|---|
| P/S (ttm): | 1.77 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.14 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.02 |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | 1.19 |
|---|
Business Summary
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United S...
View More